EUVIMEDEUVIMED entdecken
Multizentrische Studie

Oncological safety of fertility preservation treatment in ovarian cancer: A Spanish multicenter study

Marta Heras iD, Leticia Azcona, Octavio Arencibia, Lucas Minig, Lola Marti, Alicia Hernandez, Arantxa Lekuona, Isabel Niguez, Blanca Gil-Ibañez, Berta Diaz-Feijoo, Laia Ribot, Maria Nieves Cabezas und 9 weitere

International Journal of Gynecology & Obstetrics · 2025

DOI: 10.1002/ijgo.16026 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Marta Heras und 20 weiteren Autor:innen. Beteiligte Einrichtung: Gynecology Department, Hospital Universitario Santa Cristina, Madrid, Spain. Hauptthemen laut MEDLINE: Fertility Preservation, Ovarian Neoplasms. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To assess the safety of fertility‐sparing treatments for early‐stage ovarian cancer in women younger than 40 years old.

Methods

We performed a retrospective multicenter study including women aged 18–40 years diagnosed with early‐stage (FIGO I–II) ovarian cancer in 55 Spanish hospitals, from January 2010 to December 2019. Benign and borderline tumors were excluded, as well as advanced stages (FIGO III–IV). All perioperative characteristics and follow‐up data were collected and analyzed. Standard staging surgery (SSS) was compared with fertility‐sparing surgery (FSS) in terms of oncological outcomes.

Results

In all, 366 women were included; 327 (89.3%) were stage I. Among all patients, 216 (59%) underwent SSS and 150 (41%) FSS. Up to 208 (56.8%) patients did not have children, but only 12 (3.2%) had oocyte preservation before treatment. Patients in the FSS group compared with the SSS group showed a non‐significant difference in recurrences (8% vs. 9.3%, respectively; P < 0.711) and deaths (1.3% vs. 4.8%, respectively; P = 0.211) during the follow‐up. No significant differences were found between epithelial and non‐epithelial ovarian cancer both in recurrences (7.1% vs. 8.8%, respectively; P = 0.771) and in deaths (1.4% vs. 1.3%, respectively; P = 1) among patients who underwent FSS.

Conclusion

FSS seems a safe option for treatment of early‐stage ovarian cancer in patients who want to preserve fertility, either for epithelial and non‐epithelial histology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fertility PreservationOvarian NeoplasmsHumansFemaleRetrospective StudiesAdultSpainYoung AdultAdolescentNeoplasm StagingNeoplasm Recurrence, Local

Stichwörter der Autor:innen

cancerfertilityovarypregnancyprognosis

Autor:innen und Institutionen

  • Gynecology Department, Hospital Universitario Santa Cristina, Madrid, Spain.
  • Gynecology Department, Hospital Universitario Virgen de la Macarena, Seville, Spain.
  • Gynecology Department, Hospital Universitario Insular Materno Infantil de Canarias, Gran Canaria, Spain.
  • Gynecology Department, IMED Hospitales, Valencia, Spain.
  • Gynecology Department, Hospital Universitario Bellvitge, Barcelona, Spain.
  • Gynecologic Oncology Unit, La Paz University Hospital, Madrid, Spain.

ORCID-Profile: Marta Heras, Mikel Gorostidi

Zitieren

APA

Heras, M., Azcona, L., Arencibia, O., Minig, L., Marti, L., Hernandez, A., Lekuona, A., Niguez, I., Gil-Ibañez, B., Diaz-Feijoo, B., Ribot, L., Cabezas, M. N., Lamarca, M., Bellon, M., Alkourdi, A., Cardenas, L., Boldo, A., Amengual, J., Gorostidi, M., …, & YOC‐Care Collaborative Group (2025). Oncological safety of fertility preservation treatment in ovarian cancer: A Spanish multicenter study. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.16026

Vancouver

Heras M, Azcona L, Arencibia O, Minig L, Marti L, Hernandez A, et al. Oncological safety of fertility preservation treatment in ovarian cancer: A Spanish multicenter study. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.16026

BibTeX
@article{Heras2025,
  author = {Heras, Marta and Azcona, Leticia and Arencibia, Octavio and Minig, Lucas and Marti, Lola and Hernandez, Alicia and Lekuona, Arantxa and Niguez, Isabel and Gil-Ibañez, Blanca and Diaz-Feijoo, Berta and Ribot, Laia and Cabezas, Maria Nieves and Lamarca, Marta and Bellon, Monica and Alkourdi, Amira and Cardenas, Laura and Boldo, Ana and Amengual, Joana and Gorostidi, Mikel and Zapardiel, Ignacio and YOC‐Care Collaborative Group, YOC‐Care Collaborative Group},
  title = {Oncological safety of fertility preservation treatment in ovarian cancer: A Spanish multicenter study},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2025},
  doi = {10.1002/ijgo.16026}
}
Kostenlos starten →